Literature DB >> 20890584

Epithelial-to-mesenchymal transition in pancreatic adenocarcinoma.

Carla E Cano1, Yoshiharu Motoo, Juan L Iovanna.   

Abstract

Epithelial to mesenchymal transition (EMT) is a physiologic process that allows morphological and genetic changes of carcinoma cells from an epithelial to a mesenchymal phenotype, which is the basis of the high metastatic potential of pancreatic cancer cells. EMT is triggered by various tumor microenvironmental factors, including cytokines, growth factors, and chemotherapeutic agents. This review summarizes the state-of-the-art knowledge on the molecular mechanisms that support pancreatic cancer EMT and the evidences that support its involvement in invasiveness/ aggressiveness, and the drug resistance of pancreatic cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20890584      PMCID: PMC5763765          DOI: 10.1100/tsw.2010.183

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  30 in total

Review 1.  Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer.

Authors:  Daisuke Kyuno; Hiroshi Yamaguchi; Tatsuya Ito; Tsuyoshi Kono; Yasutoshi Kimura; Masafumi Imamura; Takumi Konno; Koichi Hirata; Norimasa Sawada; Takashi Kojima
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Suppression of the epidermal growth factor receptor inhibits epithelial-mesenchymal transition in human pancreatic cancer PANC-1 cells.

Authors:  Zhi-Gang Chang; Jun-Min Wei; Chang-Fu Qin; Kun Hao; Xiao-Dong Tian; Kun Xie; Xue-Hai Xie; Yin-Mo Yang
Journal:  Dig Dis Sci       Date:  2012-01-21       Impact factor: 3.199

3.  Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype.

Authors:  Zhiwei Wang; Shadan Ali; Sanjeev Banerjee; Bin Bao; Yiwei Li; Asfar S Azmi; Murray Korc; Fazlul H Sarkar
Journal:  J Cell Physiol       Date:  2013-03       Impact factor: 6.384

4.  Quercetin 3-O-glucoside suppresses epidermal growth factor-induced migration by inhibiting EGFR signaling in pancreatic cancer cells.

Authors:  Jungwhoi Lee; Song-I Han; Jeong-Hun Yun; Jae Hoon Kim
Journal:  Tumour Biol       Date:  2015-06-26

5.  DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.

Authors:  Jungwhoi Lee; Jungsul Lee; Jeong-Hun Yun; Dae Gwin Jeong; Jae Hoon Kim
Journal:  Tumour Biol       Date:  2016-05-26

6.  Filamin A expression correlates with proliferation and invasive properties of human metastatic melanoma tumors: implications for survival in patients.

Authors:  Kai Zhang; Tienian Zhu; Dongmei Gao; Yimei Zhang; Qinglan Zhao; Shuang Liu; Tongyi Su; Michel Bernier; Ruijing Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-08       Impact factor: 4.553

7.  GLI1 inhibition promotes epithelial-to-mesenchymal transition in pancreatic cancer cells.

Authors:  Simon Joost; Luciana L Almada; Verena Rohnalter; Philipp S Holz; Anne M Vrabel; Maite G Fernandez-Barrena; Robert R McWilliams; Michael Krause; Martin E Fernandez-Zapico; Matthias Lauth
Journal:  Cancer Res       Date:  2011-11-15       Impact factor: 12.701

8.  Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.

Authors:  Vindhya Palagani; Mona El Khatib; Uta Kossatz; Przemyslaw Bozko; Martin R Müller; Michael P Manns; Till Krech; Nisar P Malek; Ruben R Plentz
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

9.  Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro.

Authors:  Shao-Jie Chen; Yin-Ting Chen; Lin-Juan Zeng; Qiu-Bo Zhang; Guo-da Lian; Jia-Jia Li; Ke-Ge Yang; Chu-Mei Huang; Ya-Qing Li; Zhong-Hua Chu; Kai-Hong Huang
Journal:  Tumour Biol       Date:  2016-03-08

10.  Taurolidine induces epithelial-mesenchymal transition via up-regulation of the transcription factor Snail in human pancreatic cancer cell lines.

Authors:  Birgit Hotz; Ulrike Erben; Marco Arndt; Heinz J Buhr; Hubert G Hotz
Journal:  Int J Colorectal Dis       Date:  2014-09-03       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.